Corbus Pharmaceuticals's total assets for Q1 2025 were $139.93M, a decrease of -10.23% from the previous quarter. CRBP total liabilities were $12.82M for the fiscal quarter, a -4.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.